- IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
- IGC Pharma to Attend BIO International Convention 2024
- IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
- IGC Pharma Adds Advisor in Artificial Intelligence
- IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
- IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
- IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
- IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
More ▼
Key statistics
On Friday, IGC Pharma Inc (IGC:ASQ) closed at 0.432, 72.73% above the 52 week low of 0.2501 set on Dec 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4301 |
---|---|
High | 0.4498 |
Low | 0.4301 |
Bid | 0.4259 |
Offer | 0.4275 |
Previous close | 0.4328 |
Average volume | 237.42k |
---|---|
Shares outstanding | 66.54m |
Free float | 52.94m |
P/E (TTM) | -- |
Market cap | 31.58m USD |
EPS (TTM) | -0.2479 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼